|
| | HARMALINE Basic information |
| Product Name: | HARMALINE | | Synonyms: | 1-METHYL-7-METHOXY-3,4-DIHYDRO-BETA-CARBOLINE;TIMTEC-BB SBB003407;1-Methyl-7-methoxy-3,4-dihydroxy-beta-carboline;1-methyl-7-methoxy-3,4-dihydro-β-carboline;HARMALINE(EXTRACTFORMPEGANUMHARMALAROOTS);3,4-Dihydro-7-methoxy-1-methyl-beta-carboline
3,4-Dihydro-7-methoxy-1-methyl-9H-pyrido[3,4-b]indole
Dihydroharmine;NSC 407285;PYRIDE(3,4-B)INDOLE,4,9-DIHYDRO-7-METHOXY-1-METHYL- | | CAS: | 304-21-2 | | MF: | C13H14N2O | | MW: | 214.26 | | EINECS: | 206-152-6 | | Product Categories: | Inhibitors;Indoles and derivatives;Heterocyclic Compounds | | Mol File: | 304-21-2.mol |  |
| | HARMALINE Chemical Properties |
| | HARMALINE Usage And Synthesis |
| Uses | CNS stimulant, antiparkinsonian agent | | Uses | CNS stimulant; may act through NMDA receptors. Reversible inhibitor of MAO-A | | Definition | ChEBI: A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7 and has been reduced across the 3,4 bond. | | Synthesis Reference(s) | Canadian Journal of Chemistry, 37, p. 1851, 1959 DOI: 10.1139/v59-272 | | Purification Methods | Recrystallise harmaline from MeOH and sublime it at high vacuum. It has UV in MeOH a |
| | HARMALINE Preparation Products And Raw materials |
|
